News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Ensitrelvir safe, effective in preventing COVID-19 in households
21 Mar 2025
byStephen Padilla
Treatment with ensitrelvir among household contacts (HHC) of index patients (IP) with COVID-19 within 72 h after the onset of IP symptoms demonstrates efficacy and an acceptable safety profile as postexposure prophylaxis (PEP) in SCORPIO-PEP, a phase III placebo-controlled trial.
21 Mar 2025








